The large study that led to the approval of Entresto was stopped early because early results showed strong benefits. The combination was compared to enalapril, which itself is a highly effective heart failure treatment. People taking sacubitril + valsartan had significantly lower rates of hospitalization for heart failure and death due to cardiovascular causes than those taking enalapril. People in both groups were also taking other recommended heart failure drugs.
This answer was adapted from Sharecare's award-winning AskMD app. Start a consultation now to find out what's causing your symptoms, learn how to manage a condition, or find a doctor.
Continue Learning about Heart Failure Treatment
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.